Abstracts Archive - Page 247 of 1683 - ATC Abstracts

2021 American Transplant Congress
Risk Factors for Mortality in Kidney Transplant Patients Infected by Sars-cov-2 in South of Spain
V. Lopez¹, T. Vazquez¹, C. Casas¹, I. Poveda², J. Alonso¹, D. Hernandez¹
¹Nephrology, Nephrology Department, Hospital Regional Universitario de Málaga and University of Málaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, Málaga, Spain, ²Nephrology, Nephrology Department, Hospital Torrecárdenas, Almería., Málaga, Spain
*Purpose: Covid-19 pandemic has especially affected kidney transplant (KT) recipients, who are more vulnerable than the general population due to their immunosuppressive status and added…
2021 American Transplant Congress
I Would Do Whatever It Took”: Understanding the Motivation, Education and Experiences of Kidney Paired Donation Participants
R. Pines¹, Y. A. Iraheta², L. Ambriz², K. A. Dahmani², E. H. Wood², M. Cooper³, A. D. Waterman²
¹Santa Barbara Cottage Hospital, Santa Barbara, CA, ²UCLA David Geffen School of Medicine, Los Angeles, CA, ³Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: To improve kidney paired donation (KPD) educational programs, we conducted semi-structured interviews to understand motivations of past recipients and donors to participate in KPD,…
2021 American Transplant Congress
Serum Phosphatidylethanol is Superior to Urine Ethyl Glucuronide for Diagnosis of Alcohol Relapse in Liver Transplant Recipients
N. Lim¹, T. Leventhal¹, M. Thomson¹, M. Hassan¹, J. Thompson¹, S. Chinnakotla², V. Kirchner², T. Pruett², R. Kandaswamy², V. Humphreville², A. Adams², J. Lake¹
¹Divison of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, ²Divison of Transplantation, University of Minnesota, Minneapolis, MN
*Purpose: Liver transplantation (LT) for alcohol-related liver disease (ALD) is increasing. The primary issue in these patients is often recidivism, therefore screening for ETOH use…
2021 American Transplant Congress
Perioperative Terlipressin Therapy Reduces the Risk of Acute Kidney Injury Post-Living Donor Liver Transplantation – A Systematic Review and Meta-analysis
A. V. Kulkarni, H. V. Tevethia, M. Sharma, P. Kumar, N. P. Rao, N. D. Reddy
Hepatology and Liver Transplantation, Asian Institute of Gastroenterology, Hyderabad, India
*Purpose: Acute kidney injury (AKI) after liver transplantation precludes calcineurin inhibitors' therapy and is associated with poor outcomes. Terlipressin (Tp) has mortality benefit in pre-transplant…
2021 American Transplant Congress
Combined Liver-Kidney Transplantation in Adults With End-Stage Liver Disease: Risk Factors in Patients with Chronic Kidney Disease Stages 3-5, Not on Maintenance Dialysis
A. Santos, E. Bueno, M. Leghrouz
University of Florida, Gainesville, FL
*Purpose: We aimed to identify the risk factors for combined liver-kidney transplantation (CLKT) vs. liver transplantation alone (LTA) in end stage liver disease (ESLD) patients…
2021 American Transplant Congress
Who Can be Matched via Kidney Exchange?
D. C. McElfresh¹, M. Curry², S. E. Booker³, D. Stewart³, M. Stuart³, R. Leishman⁴, T. Sandholm⁵, J. Dickerson²
¹Applied Mathematics, University of Maryland, College Park, MD, ²Computer Science, University of Maryland, College Park, MD, ³United Network for Organ Sharing, Seattle, WA, ⁴UNOS, Seattle, WA, ⁵Computer Science, Carnegie Mellon University, Pittsburgh, PA
*Purpose: Valuable time and resources are spent screening medically-compatible patients and donors for kidney exchange. Exchanges with tens or hundreds of patients can have thousands…
2021 American Transplant Congress
Detection of Rejection in Kidney Transplant Patients Using an Algorithm That Combines Donor Fraction and Absolute Donor-derived Cell-free DNA
S. Bunnapradist¹, E. Ahmed², M. Maninder², Z. P. Demko², P. R. Billings², H. Tabriziani², P. Gauthier³
¹David Geffen Sch of Med @ UCLA, Los Angeles, CA, ²Natera, Inc., San Carlos, CA, ³Natera, Inc., Los Angeles, CA
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) in the plasma of renal allograft patients is a clinically validated biomarker for allograft injury and rejection. Several dd-cfDNA assays…
2021 American Transplant Congress
Hepatic Artery Thrombosis and Liver Transplantation: Patient Management and Candidate Selection for Re-transplantation
H. Fernandez, A. Wall, A. Gupta, E. Martinez, J. Bayer, G. McKenna, N. Onaca, R. Ruiz, C. Spak, G. Testa
Baylor University Medical Center, Dallas, TX
*Purpose: Hepatic artery thrombosis (HAT) is a severe complication in liver transplantation (OLTX). Re-OLTX for patients with HAT has been met with controversy due to…
2021 American Transplant Congress
A Significantly Shorter Waiting Time to Subsequent Kidney Transplant After Liver Transplant by Using Safety Net Policy
P. Homkrailas, S. Bunnapradist
Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: In August 2017, a new simultaneous liver-kidney transplant (SLK) allocation policy and medical eligibility criteria were introduced. These criteria aim to avoid dual organ…
2021 American Transplant Congress
Impact of Social Support, Social Circumstances and Distance from Transplant Center on Post Liver Transplant Outcomes: An Analysis from a Predominantly Rural U.S. Cohort
R. Kaur¹, C. Lavender¹, E. Askew¹, S. Jafri², R. Thandassery¹, M. Deneke¹
¹University of Arkansas for Medical Sciences, Little Rock, AR, ²Henry Ford Hospital, Detroit, MI
*Purpose: Social support and social circumstances (SSSC) are critical yet less described entities in post-orthotopic liver transplant (OLT). We aimed to describe SSSC and correlate…